-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On the basis of the first batch of 19 inter-provincial alliances, Hubei invited all provinces across the country to establish a procurement mechanism for
the National Proprietary Chinese Medicine Alliance.
The National Proprietary Chinese Medicine Collection Alliance continued the concept of the first batch of proprietary Chinese medicines, and formed 16 procurement groups containing 42 drugs in accordance with the principle of "large clinical use and high procurement amount", with an estimated market amount of more than 10 billion yuan
.
the National Proprietary Chinese Medicine Alliance.
The National Proprietary Chinese Medicine Collection Alliance continued the concept of the first batch of proprietary Chinese medicines, and formed 16 procurement groups containing 42 drugs in accordance with the principle of "large clinical use and high procurement amount", with an estimated market amount of more than 10 billion yuan
.
The Hubei Inter-regional Interprovincial Procurement Alliance of Chinese Proprietary Medicines covers 30 provinces and municipalities (including the Xinjiang Corps), except for Hong Kong, Macao and Taiwan, Fujian and Hunan, the rest of the provinces have joined the alliance, which can be called the "small national collection"
of proprietary Chinese medicine.
of proprietary Chinese medicine.
On September 20, Hubei Pharmaceutical Price and Bidding Procurement Management Service Network issued the "Notice of the National Proprietary Chinese Medicine Joint Procurement Office on Filling in the Relevant Procurement Data of the Scope of Procurement Varieties of the Chinese Proprietary Medicine Alliance", and the Beijing Municipal Medical Security Bureau also issued the "Notice of the Beijing Municipal Medical Security Bureau on Filling in the Procurement Data Information Related to the Procurement Range of the Procurement Varieties of the Chinese Proprietary Medicine Alliance"
.
.
Reporting time for medical institutions: 0:00 on September 22, 2022 - 24:00 on September 30, 2022
.
After the completion of the reporting time, no supplementary data reports
will be accepted.
.
After the completion of the reporting time, no supplementary data reports
will be accepted.
Review time of medical insurance departments at all levels: 0:00 on September 26, 2022 to 24:00 on October 10, 2022
.
.
The provincial medical insurance departments in the alliance area organize the review of the historical procurement volume and procurement demand of medical institutions
.
In principle, the historical procurement volume reported by the medical institution shall not be lower than the actual procurement volume of the procurement platform in 2021; If the completed procurement demand does not reach 80% of the historical procurement volume, it shall be reported
after data correction or submission of relevant explanations.
.
In principle, the historical procurement volume reported by the medical institution shall not be lower than the actual procurement volume of the procurement platform in 2021; If the completed procurement demand does not reach 80% of the historical procurement volume, it shall be reported
after data correction or submission of relevant explanations.
The notice of Beijing Municipality makes it clear that medical institutions shall, in accordance with the catalogue of varieties and refer to the historical procurement data of the procurement platform, truthfully fill in the historical purchase volume, purchase price and purchase amount of each product actually used in 2021; Combined with historical use, clinical drug demand and other factors, accurately fill in the procurement demand of each product in the next year, and explain
the products that are significantly different from the historical procurement demand filled in.
the products that are significantly different from the historical procurement demand filled in.
On the basis of the first batch of 19 inter-provincial alliances, Hubei invited all provinces across the country to establish a procurement mechanism for
the National Proprietary Chinese Medicine Alliance.
The National Proprietary Chinese Medicine Collection Alliance continued the concept of the first batch of proprietary Chinese medicines, and formed 16 procurement groups containing 42 drugs in accordance with the principle of "large clinical use and high procurement amount", with an estimated market amount of more than 10 billion yuan
.
the National Proprietary Chinese Medicine Alliance.
The National Proprietary Chinese Medicine Collection Alliance continued the concept of the first batch of proprietary Chinese medicines, and formed 16 procurement groups containing 42 drugs in accordance with the principle of "large clinical use and high procurement amount", with an estimated market amount of more than 10 billion yuan
.
The Hubei Inter-regional Interprovincial Procurement Alliance of Chinese Proprietary Medicines covers 30 provinces and municipalities (including the Xinjiang Corps), except for Hong Kong, Macao and Taiwan, Fujian and Hunan, the rest of the provinces have joined the alliance, which can be called the "small national collection"
of proprietary Chinese medicine.
of proprietary Chinese medicine.
On September 20, Hubei Pharmaceutical Price and Bidding Procurement Management Service Network issued the "Notice of the National Proprietary Chinese Medicine Joint Procurement Office on Filling in the Relevant Procurement Data of the Scope of Procurement Varieties of the Chinese Proprietary Medicine Alliance", and the Beijing Municipal Medical Security Bureau also issued the "Notice of the Beijing Municipal Medical Security Bureau on Filling in the Procurement Data Information Related to the Procurement Range of the Procurement Varieties of the Chinese Proprietary Medicine Alliance"
.
Pharmaceutical and pharmaceutical bidding bidding procurement procurement.
Reporting time for medical institutions: 0:00 on September 22, 2022 - 24:00 on September 30, 2022
.
After the completion of the reporting time, no supplementary data reports
will be accepted.
.
After the completion of the reporting time, no supplementary data reports
will be accepted.
Review time of medical insurance departments at all levels: 0:00 on September 26, 2022 to 24:00 on October 10, 2022
.
.
The provincial medical insurance departments in the alliance area organize the review of the historical procurement volume and procurement demand of medical institutions
.
In principle, the historical procurement volume reported by the medical institution shall not be lower than the actual procurement volume of the procurement platform in 2021; If the completed procurement demand does not reach 80% of the historical procurement volume, it shall be reported
after data correction or submission of relevant explanations.
.
In principle, the historical procurement volume reported by the medical institution shall not be lower than the actual procurement volume of the procurement platform in 2021; If the completed procurement demand does not reach 80% of the historical procurement volume, it shall be reported
after data correction or submission of relevant explanations.
The notice of Beijing Municipality makes it clear that medical institutions shall, in accordance with the catalogue of varieties and refer to the historical procurement data of the procurement platform, truthfully fill in the historical purchase volume, purchase price and purchase amount of each product actually used in 2021; Combined with historical use, clinical drug demand and other factors, accurately fill in the procurement demand of each product in the next year, and explain
the products that are significantly different from the historical procurement demand filled in.
the products that are significantly different from the historical procurement demand filled in.
